ReviewNature reviews. Drug discovery2020
Leveraging preclinical models for the development of Alzheimer disease therapeutics.
Kimberly Scearce-Levie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
65 papers cite itlatest 60 shown
this papercites it